GlassScriptPhysician profile
Heather J Porter
NPI 1215990585
$15,226.61
in general payments reported to CMS, 2019-2025
54 companies · $2,198 in 2025
The $2,198 reported for 2025 was more than what 96% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,631 · 2020: $1,619 · 2021: $2,129 · 2022: $2,137 · 2023: $2,318 · 2024: $2,195 · 2025: $2,198.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,700 · Education: $10.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,700.31 |
| Education | $10.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $1,565.39 | 2019-2025 | |
| Glaxosmithkline, LLC. | $1,390.33 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Abbvie INC. | $1,357.21 | 2019-2025 | |
| Lilly USA, LLC | $1,212.23 | 2019-2025 | Mounjaro, Zepbound, Trulicity |
| Astrazeneca Pharmaceuticals LP | $1,168.75 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,045.53 | 2019-2025 | Jardiance, Ofev, Jascayd |
| Novo Nordisk INC | $983.66 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $803.00 | 2019-2025 | Repatha, Otezla, Otezla |
| Janssen Pharmaceuticals, INC | $652.51 | 2019-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $576.26 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $575.82 | 2019-2025 | Verquvo, Belsomra, Gardasil 9 |
| Kowa Pharmaceuticals America, INC. | $323.87 | 2019-2025 | Zoryve, Seglentis, Livalo |
| E.R. Squibb & Sons, L.L.C. | $309.55 | 2019-2025 | Eliquis, Camzyos |
| Amarin Pharma, INC. | $275.70 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $257.93 | 2021-2025 |
Show all 54 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Porter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.